| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
1,519,721 | 606,423 | 363,707 | 305,208 | 245,358 |
|
Cost of Revenue
|
-237,067 | -122,938 | -85,742 | -65,573 | -55,126 |
|
Gross Profit
|
1,282,654 | 483,485 | 277,965 | 239,635 | 190,232 |
| Selling, General and Administrative Expenses
|
-960,238 | -701,167 | -461,116 | -344,501 | -265,784 |
|
Research and Development Expenses
|
-944,393 | -771,093 | -598,367 | -571,011 | -397,518 |
| Depreciation, Amortization and Depletion
|
-11,149 | -6,001 | -5,052 | -5,052 | -5,053 |
|
Operating Income/Expenses
|
-1,915,780 | -1,478,261 | -1,064,535 | -920,564 | -668,355 |
|
Total Operating Profit/Loss
|
-633,126 | -994,776 | -786,570 | -680,929 | -478,123 |
| Total Net Finance Income/Expense
|
-81,364 | -83,795 | -84,913 | -81,694 | -26,446 |
| Net Investment Income
|
49,325 | 60,656 | 53,071 | 42,452 | 9,555 |
| Irregular Income/Expenses
|
69,141 | -251,993 | -91,682 | -28,697 | 20,802 |
|
Other Income/Expense, Non-Operating
|
-2,034 | -1,841 | 29 | 1,856 | -5,939 |
|
Non-Operating Income/Expenses, Total
|
35,068 | -276,973 | -123,495 | -66,083 | -2,028 |
|
Pretax Income
|
-598,058 | -1,271,749 | -910,065 | -747,012 | -480,151 |
|
Provision for Income Tax
|
-7,551 | -5,026 | -3,707 | -2,555 | -1,383 |
|
Net Income from Continuing Operations
|
-605,609 | -1,276,775 | -913,772 | -749,567 | -481,534 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-605,609 | -1,276,775 | -913,772 | -749,567 | -481,534 |
|
Net Income after Non-Controlling/Minority Interests
|
-605,609 | -1,276,775 | -913,772 | -749,567 | -481,534 |
|
Net Income Available to Common Stockholders
|
-605,609 | -1,276,775 | -913,772 | -749,567 | -481,534 |
|
Diluted Net Income Available to Common Stockholders
|
-605,609 | -1,276,775 | -913,772 | -749,567 | -481,534 |
| Basic EPS
|
-2.82 | -6.42 | -5.57 | -5.34 | -3.91 |
| Diluted EPS
|
-2.82 | -6.42 | -5.57 | -5.34 | -3.91 |
|
Basic Weighted Average Shares Outstanding
|
216,360 | 199,014 | 164,043 | 140,433 | 123,035 |
|
Diluted Weighted Average Shares Outstanding
|
216,360 | 199,014 | 164,043 | 140,433 | 123,035 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-522,361 | -1,194,170 | -832,036 | -672,638 | -457,696 |
|
EBITDA
|
-498,129 | -1,177,770 | -820,936 | -662,038 | -447,296 |
|
Normalized EBITDA
|
-400,003 | -773,067 | -632,183 | -558,883 | -408,886 |
|
Normalized Income
|
-532,573.82 | -975,554.56 | -764,657.13 | -668,074.55 | -451,190.10 |
|
Total Unusual Items
|
98,126 | 404,703 | 188,753 | 103,155 | 38,410 |
12/31/2022 - 2/2/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade